Biotech News
Related news
AORTArtivion2026-10-22 20:10 EST
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2026 Financial Results
AORTArtivion2026-11-05 21:05 EST
Artivion Reports Third Quarter 2026 Financial Results
CVRXCVRx2026-11-02 21:02 EST
CVRx to Participate in Upcoming Investor Conferences
ANGOAngioDynamics2026-10-29 12:00 EST
AngioDynamics to Participate in Upcoming Investor Conferences
LUNGPulmonx2026-10-28 20:05 EST
Pulmonx to Participate in Upcoming Investor Conferences
DCTHDelcath Systems2026-10-27 12:30 EST
Delcath Systems to Participate in Upcoming Investor Conferences
ATRCAtriCure2026-10-26 12:00 EST
AtriCure to Participate at Upcoming Investor Conferences
SENSSenseonics2026-10-22 12:00 EST
Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences
APYXApyx Medical2026-10-21 12:00 EST
Apyx Medical Corporation to Participate in Upcoming Investor Conferences
SENSSenseonics2026-09-10 12:00 EST
Senseonics To Participate in Upcoming Institutional Investor Conferences
Artivion
Aortic-Disease Technologies Artivion develops medical devices and implantable tissues for complex aortic and cardiac surgery. Its portfolio is designed around the needs of cardiac and vascular surgeons treating life-threatening aortic disease. Surgical Products The company supplies aortic stent grafts, surgical adhesives, mechanical...
Recent company news
AORTArtivion2026-11-05 21:05 EST
Artivion Reports Third Quarter 2026 Financial Results
AORTArtivion2026-10-28 20:10 EST
Artivion to Participate in Upcoming Investor Conferences
AORTArtivion2026-10-22 20:10 EST
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2026 Financial Results
AORTArtivion2026-08-06 20:05 EST
Artivion Reports Second Quarter 2026 Financial Results
AORTArtivion2026-07-28 20:10 EST
Artivion to Participate in Upcoming Investor Conferences
Stock data
- Close
- 25.33 USD
- Market cap
- 991.26M USD
- Exchange
- NYSE
- Sector
- MedTech
- Location
- United States